487 filings
6-K
CYTO
Altamira Therapeutics Ltd
16 May 24
Report of Foreign Private Issuer
4:15pm
20-F/A
2023 FY
CYTO
Altamira Therapeutics Ltd
22 Apr 24
Annual report (foreign) (amended)
4:31pm
EFFECT
CYTO
Altamira Therapeutics Ltd
18 Apr 24
Notice of effectiveness
12:15am
424B4
CYTO
Altamira Therapeutics Ltd
17 Apr 24
Prospectus supplement with pricing info
4:20pm
6-K
CYTO
Altamira Therapeutics Ltd
16 Apr 24
Notice of the Annual General Meeting of Shareholders
5:00pm
6-K
6f93lbrx
10 Apr 24
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
8:30am
S-8
cp3u9ssw5de
10 Apr 24
Registration of securities for employees
8:15am
F-1
eq6zmfyxg6jxsf8x2c
10 Apr 24
Registration statement (foreign)
8:15am
SC 13D/A
8v5e7fuycwig
13 Mar 24
Altamira Therapeutics / Meyer Thomas ownership change
11:03am
424B4
4pwyxq4x
22 Jan 24
Prospectus supplement with pricing info
5:02pm
EFFECT
f8kwkvh7z6qe6xwkt
22 Jan 24
Notice of effectiveness
12:15am
6-K
m77c97krna0gkvftaau8
19 Jan 24
Report of Foreign Private Issuer
4:45pm
424B5
i4ux9zua30 92lq
19 Jan 24
Prospectus supplement for primary offering
4:40pm
6-K
0alruag o5
19 Jan 24
Report of Foreign Private Issuer
4:30pm
CORRESP
9ihvo
17 Jan 24
Correspondence with SEC
12:00am
UPLOAD
ajo x960h
16 Jan 24
Letter from SEC
12:00am
F-3
vfxzq
8 Jan 24
Shelf registration (foreign)
5:02pm
6-K
9mpjtx9sgf28
11 Dec 23
Altamira Therapeutics Provides Investor and Business Update
8:01am
6-K
u4a6npive24c ym6
11 Dec 23
Report of Foreign Private Issuer
8:00am